Skip to main content

Table 2 Characteristics of the propensity score-matched patients

From: Comparison of the outcomes of stereotactic body radiotherapy versus surgical treatment for elderly (≥70) patients with early-stage non-small cell lung cancer after propensity score matching

Factor

SBRT

(N = 35)

Surgery

(N = 35)

p-value

Age (years)

 Median (range)

76 (70–83)

74 (70–83)

0.226

Gender

 Male

22

22

1.000

 Female

13

13

 

Tumor size (cm)

 Median (range)

2.1 (1.4–5.0)

2.2 (1.2–4.0)

0.982

T stage

 T1

28

27

0.919

 T2

7

8

 

Histology

 NSCLC-NOS

6

2

0.011

 SCC

9

11

 

 Ade

16

22

 

 probable

4

0

 

FEV1

 Median (range)

1.58 (0.55–2.40)

1.53 (0.87–2.62)

0.872

FEV1/FVC (%)

 Median (range)

101 (64–129)

103 (54–125)

0.765

CCI (%)

 0

27 (77)

24 (68)

0.503

 1–2

7 (18)

9 (26)

 

 ≥ 3

1 (3)

2 (6)

 

KPS

 Median (range)

90 (70–100)

90 (80–100)

0.097

Tumor location

 RUL

9

10

0.084

 RML

8

5

 

 RLL

7

6

 

 LUL

5

9

 

 LLL

6

5

 

SBRT dose

 50Gy/4fx

8

 

N/A

 50Gy/5fx

19

  

 50Gy/10fx

5

  

 60Gy/8fx

2

  

 70Gy/10fx

1

  

Operation

 lobectomy

 

29

N/A

 sublobar resection

 

6

 

 VATS

 

26

 

 thoracotomy

 

9

 
  1. SBRT stereotactic body radiotherapy, NSCLC non–small cell lung cancer, NOS not otherwise specified, Ade adenocarcinoma, SCC squamous cell carcinoma, FEV1 forced expiratory volume in 1 s, FEV1/FVC% FEV1 to forced vital capacity ratio, CCI Charlson comorbidity index, KPS Karnofsky performance status, fx fraction, RUL right upper lobe, RML right middle lobe, RLL right lower lobe, LUL left upper lobe, LLL left lower lobe, VATS video-assisted thoracic surgery